Investor Relations Home
Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings.
|Recent Press Releases||More >>|
|Date||Title|| || |
|08/10/18||Omeros to Present at the 2018 Wedbush PacGrow Healthcare Conference|
|SEATTLE--(BUSINESS WIRE)--Aug. 10, 2018--
Omeros Corporation (NASDAQ: OMER), today announced that Gregory A.
Demopulos, M.D., chairman and chief executive officer, will present at
the 2018 Wedbush PacGrow Healthcare Conference in New York next week.
The presentation is scheduled for Tuesday, August 14, 2018 at 2:30 p.m.
The presentation will be webcast. The live and archived webcasts can be
accessed on the “Events” page of the company... || |
|08/09/18||Omeros Corporation Reports Second Quarter 2018 Financial Results|
|– Conference Call Today at 4:30 p.m. ET –
SEATTLE--(BUSINESS WIRE)--Aug. 9, 2018--
Omeros Corporation (NASDAQ: OMER) today announced recent highlights and
developments as well as financial results for the second quarter ended
June 30, 2018, which include:
2Q 2018 total and OMIDRIA® revenues were $1.7 million,
compared to $17.2 million in 2Q 2017; the decrease was due to the
significantly reduced usage of OMIDRIA by ambula... || |
|08/03/18||Omeros Corporation to Announce Second Quarter 2018 Financial Results on August 9, 2018|
|SEATTLE--(BUSINESS WIRE)--Aug. 3, 2018--
Omeros Corporation (NASDAQ: OMER) today announced that the company will
issue its second quarter 2018 financial results for the period ended
June 30, 2018, on Thursday, August 9, 2018, after the market closes.
Omeros management will host a conference call and webcast that day at
4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial
Conference Call Details
T... || |
|08/02/18||Omeros Hires Former Sanofi Global Development Head as Chief Medical Officer|
|– Company Expands Leadership to Keep Pace with
Advancing Pivotal Clinical Programs –
SEATTLE--(BUSINESS WIRE)--Aug. 2, 2018--
Omeros Corporation (Nasdaq: OMER) today announced that Eckhard Leifke,
M.D. has been named Omeros’ Chief Medical Officer and Vice President of
Clinical Development. In this role, Dr. Leifke will oversee clinical
science & operations, medical affairs and pharmacovigilance. He assumes
these corporate responsibilities ... || |
|There are currently no events scheduled.|
Receive E-mail Alerts|
|Sign up to receive e-mail alerts whenever Omeros Corporation posts new information to the site. Just enter your e-mail address and click Submit.|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.